Rodolakis, I.; Pergialiotis, V.; Liontos, M.; Haidopoulos, D.; Loutradis, D.; Rodolakis, A.; Bamias, A.; Thomakos, N.
Chemotherapy Response Score in Ovarian Cancer Patients: An Overview of Its Clinical Utility. J. Clin. Med. 2023, 12, 2155.
https://doi.org/10.3390/jcm12062155
AMA Style
Rodolakis I, Pergialiotis V, Liontos M, Haidopoulos D, Loutradis D, Rodolakis A, Bamias A, Thomakos N.
Chemotherapy Response Score in Ovarian Cancer Patients: An Overview of Its Clinical Utility. Journal of Clinical Medicine. 2023; 12(6):2155.
https://doi.org/10.3390/jcm12062155
Chicago/Turabian Style
Rodolakis, Ioannis, Vasilios Pergialiotis, Michalis Liontos, Dimitrios Haidopoulos, Dimitrios Loutradis, Alexandros Rodolakis, Aristotelis Bamias, and Nikolaos Thomakos.
2023. "Chemotherapy Response Score in Ovarian Cancer Patients: An Overview of Its Clinical Utility" Journal of Clinical Medicine 12, no. 6: 2155.
https://doi.org/10.3390/jcm12062155
APA Style
Rodolakis, I., Pergialiotis, V., Liontos, M., Haidopoulos, D., Loutradis, D., Rodolakis, A., Bamias, A., & Thomakos, N.
(2023). Chemotherapy Response Score in Ovarian Cancer Patients: An Overview of Its Clinical Utility. Journal of Clinical Medicine, 12(6), 2155.
https://doi.org/10.3390/jcm12062155
